Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Niagen Bioscience (NAGE) Return on Capital Employed (2016 - 2025)

Niagen Bioscience (NAGE) has disclosed Return on Capital Employed for 11 consecutive years, with 0.2% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Capital Employed rose 2.0% to 0.2% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.2%, a 2.0% increase, with the full-year FY2025 number at 0.24%, up 6.0% from a year prior.
  • Return on Capital Employed was 0.2% for Q4 2025 at Niagen Bioscience, down from 0.27% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.27% in Q3 2025 to a low of 0.88% in Q2 2022.
  • A 5-year average of 0.24% and a median of 0.18% in 2023 define the central range for Return on Capital Employed.
  • Peak YoY movement for Return on Capital Employed: decreased -15bps in 2022, then skyrocketed 63bps in 2023.
  • Niagen Bioscience's Return on Capital Employed stood at 0.65% in 2021, then grew by 11bps to 0.58% in 2022, then skyrocketed by 71bps to 0.17% in 2023, then skyrocketed by 204bps to 0.17% in 2024, then grew by 14bps to 0.2% in 2025.
  • Per Business Quant, the three most recent readings for NAGE's Return on Capital Employed are 0.2% (Q4 2025), 0.27% (Q3 2025), and 0.26% (Q2 2025).